Determination of 7-ketocholesterol in plasma by lc-ms for rapid diagnosis of acid smase-deficient niemann-pick disease

Journal of Lipid Research

Volumn 55, Issue 2, 2014, Pages 338-343

  Lin, Na ^a   Zhang, Huiwen ^a   Qiu, Wenjuan ^a   Ye, Jun ^a   Han, Lianshu ^a   Wang, Yu ^a   Gu, Xuefan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Genetics; Mass spectrometry; Oxysterols; Storage diseases

Indexed keywords

GENETICS; MASS SPECTROMETRY; OXYSTEROLS; STORAGE DISEASES;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; HETEROZYGOTE; HUMANS; KETOCHOLESTEROLS; MASS SPECTROMETRY; NIEMANN-PICK DISEASE, TYPE C; NIEMANN-PICK DISEASES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SPHINGOMYELIN PHOSPHODIESTERASE; TIME FACTORS;

EID: 84893352301     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D044024     Document Type: Article

References (30)

1. Schuchman, E. H. 2007.The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J. Inherit. Metab. Dis. 30 : 654-663.
2. McGovern, M. M., and E. H. Schuchman.2006.Acid sphingomyelinase deficiency. In GeneReviews™ [Internet].
3. R. A. Pagon, M.P. Adam, T. D. Bird, et al., editors. University of Washington, Seattle, WA. Accessed November 6, 2012, at http://www.ncbi.nlm.nih. gov/ books/NBK1370/.
4. Meikle, P. J., J. J. Hopwood, A. E. Clague, and W. F. Carey.1999.Prevalence of lysosomal storage disorders. JAMA.281 : 249-254.
5. McGovern, M. M., A. Aron, S. E. Brodie, R. J. Desnick, and M. P. Wasserstein.2006.Natural history of type A Niemann-Pick disease, possible endpoints for therapeutic trials. Neurology.66 : 228-232.
6. McGovern, M. M., M. P. Wasserstein, R. Giugliani, B. Bembi, M. Vanier, E. Mengel, S. E. Brodie, D. Mendelson, G. Skloot, R. J. Desnick, et al.2008.A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B. Pediatrics.122 : e341-e349.
7. McGovern, M. M., N. Lippa, E. Bagiella, E. H. Schuchman, R. J. Desnick, and M. P. Wasserstein.2013.Morbidity and mortality in type B Niemann-Pick disease. Genet. Med. 15 : 618-623.
8. Pavlu-Pereira, H., B. Asfaw, H. Poupctová, J. Ledvinová, J. Sikora, M. T. Vanier, K. Sandhoff, J. Zeman, Z. Novotná, D. Chudoba, et al.2005.Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twentyfive Czech and Slovak patients. A multi-Approach study. J. Inherit. Metab. Dis. 28 : 203-227.
9. Wasserstein, M. P., A. Aron, S. E. Brodie, C. Simonaro, R. J. Desnick, and M. M. McGovern.2006.Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease. J. Pediatr. 149 : 554-559.
10. Rodríguez-Pascau, L., L. Gort, E. H. Schuchman, L. Vilageliu, D. Grinberg, and A. Chabás.2009.Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients. Hum. Mutat. 30 : 1117-1122.
11. Desnick, J. P., J. Kim, X. He, M. P. Wasserstein, C. M. Simonaro, and E. H. Schuchman.2010.Identification and characterization of eight novel SMPD1 mutations causing types A and B Niemann-Pick disease. Mol. Med. 16 : 316-321.
12. Pittis, M. G., V. Ricci, V. I. Guerci, C. Marçais, G. Ciana, A. Dardis, F. Gerin, M. Stroppiano, M. T. Vanier, M. Filocamo, et al.2004.Acid sphingomyelinase: identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in-frame start codon. Hum. Mutat. 24 : 186-187.
13. Zhang, H., Y. Wang, Z. Gong, X. Li, W. Qiu, L. Han, J. Ye, and X. Gu.2013.Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-defi-cient Niemann-Pick disease. Orphanet J. Rare Dis. 8 : 15.
14. Schneiderman, J., K. Thormann, J. Charrow, and M. Kletzel.2007.Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B. Pediatr. Blood Cancer.49 : 987-989.
15. Shah, A. J., N. Kapoor, G. M. Crooks, R. Parkman, K. I. Weinberg, and K. Wilson.2005.Successful hematopoietic stem cell transplantation for Niemann-Pick disease type B. Pediatrics.116 : 1022-1025.
16. Miranda, S. R., X. He, C. M. Simonaro, S. Gatt, A. Dagan, R. J. Desnick, and E. H. Schuchman.2000.Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. FASEB J. 14 : 1988-1995.
17. Ziegler, R. J., C. Brown, C. M. Barbon, A. M. D'Angona, E. H. Schuchman, L. Andrews, B. L. Thurberg, J. M. McPherson, K. P. Karey, and S. H. Cheng.2009.Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease. Mol. Genet. Metab. 97 : 35-42.
18. Desnick, R. J., and E. H. Schuchman.2012.Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu. Rev. Genomics Hum. Genet. 13 : 307-335.
19. McGovern, M. M., T. Pohl-Worgall, R. J. Deckelbaum, W. Simpson, D. Mendelson, R. J. Desnick, E. H. Schuchman, and M. P. Wasserstein.2004.Lipid abnormalities in children with types A and B Niemann Pick disease. J. Pediatr. 145 : 77-81.
20. Porter, F. D., D. E. Scherrer, M. H. Lanier, S. J. Langmade, V. Molugu, S. E. Gale, D. Olzeski, R. Sidhu, D. J. Dietzen, R. Fu, et al.2010.Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci. Transl. Med. 2 : 56ra81.
21. Jiang, X., R. Sidhu, F. D. Porter, N. M. Yanjanin, A. O. Speak, D. T. te Vruchte, F. M. Platt, H. Fujiwara, D. E. Scherrer, J. Zhang, et al.2011.A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J. Lipid Res. 52 : 1435-1445.
22. Sevanian, A., R. Seraglia, P. Traldi, P. Rossato, F. Ursini, and H. Hodis.1994.Analysis of plasma cholesterol oxidation products using gas-And high-performance liquid chromatography/mass spectrometry. Free Radic. Biol. Med. 17 : 397-409.
23. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy.1995.Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225 : 73-80.
24. Jiang, X., D. S. Ory, and X. Han.2007.Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. Rapid Commun. Mass Spectrom. 21 : 141-152.
25. Honda, A., K. Yamashita, M. Numazawa, T. Ikegami, M. Doy, and Y. Matsuzaki.2007.Highly sensitive quantification of 7a-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS. J. Lipid Res. 48 : 458-464.
26. Honda, A., K. Yamashita, T. Hara, T. Ikegami, T. Miyazaki, M. Shirai, G. Xu, M. Numazawa, and Y. Matsuzaki.2009.Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J. Lipid Res. 50 : 350-357.
27. Santa, T., O. Y. Al-Dirbashi, and T. Fukushima.2007.Derivatization reagents in liquid chromatography/electrospray ionization tandem mass spectrometry for biomedical analysis. Drug Discov. Ther. 1 : 108-118.
28. Deshmukh, N., I. Hussain, J. Barker, A. Petroczi, and D. P. Naughton.2010.Analysis of anabolic steroids in human hair using LC-MS/MS. Steroids.75 : 710-714.
29. Tint, G. S., P. Pentchev, G. Xu, A. K. Batta, S. Shefer, G. Salen, and A. Honda.1998.Cholesterol and oxygenated cholesterol concentrations are markedly elevated in peripheral tissue but not in brain from mice with the Niemann-Pick type C phenotype. J. Inherit. Metab. Dis. 21 : 853-863.
30. Zhang, J. R., T. Coleman, S. J. Langmade, D. E. Scherrer, L. Lane, M. H. Lanier, C. Feng, M. S. Sands, J. E. Schaffer, C. F. Semenkovich, et al.2008.Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J. Clin. Invest. 118 : 2281-2290.